This is read by an automated voice. Please report any issues or inconsistencies here. I’m standing outside my shower and I don’t want to go in. I’m not tired or in a rush, simply avoiding the ...
After decades of limited options for male-pattern baldness, a new topical drug has delivered encouraging results in late-stage clinical trials. Dublin-based Cosmo Pharmaceuticals has announced that ...
(MENAFN- EIN Presswire) EINPresswire/ -- Global Hair Restoration Market size is expected to nearly triple during the forecast period, increasing from USD 7.46 Bn in 2025 to USD 21.73 Bn by 2032. The ...
This has been an eventful year for me. With some trepidation, I published a memoir, How Not To Be A Political Wife. In it, I was very honest – some might say a little too honest – about a lot of ...
The topical medication, called Clascoterone, could represent the first truly novel drug for male pattern baldness seen in about 30 years. Reading time 2 minutes Are you a man worried about losing your ...
Trying to fix a thinning mane? It’s a hairy situation. More than 80% of men and nearly half of women in the US will face some form of hair loss in their lifetime, and thousands of companies are ...
Cosmo Pharmaceuticals has revealed topline results from two phase 3 trials which indicate that its topical cream clascoterone could become a game-changing treatment for male-pattern hair loss. The ...
As an editor and writer who has contributed to many national and local publications, Nicole Gregory enjoys communicating clearly on critical health topics so that readers can make informed choices for ...
“This is self-improvement season,” said Rob Spurrell, CEO of Bosley. “People are focused on looking and feeling their best, and Bosley is here to make that transformation possible in just one visit, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback